Just as the holiday season comes to a close, a new recall of one of Texas's favorite holiday treats has gone into effect, ...

The nation's top food and product regulator said there are "significant" gaps in scientists' understanding of how PFAS in ...

After years trying to create a scholarship at UT's College of Pharmacy for Hispanic scholars, Texas Exes denied it because of ...

The FDA has recalled two dog biscuit brands sold in Texas due to possible salmonella contamination. See which products are ...

Bipartisan momentum to ‘Make America Healthy Again’ will likely fuel more food-focused state action, though companies are ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

Salon workers have pushed for a ban on the chemical, which increases the risk of hormone-related cancers, since 2021.

Since the U.S. Supreme Court rolled back the constitutional right to abortion in 2022, nearly half of U.S. states have banned ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

Island Pharmaceuticals has scored a big win with the grant of a US patent relating to the use of Galidesivir in treating ...